Literature DB >> 1138583

Increased platelet aggregation in early diabetus mellitus.

J Sagel, J A Colwell, L Crook, M Laimins.   

Abstract

In view of the tendency toward vascular disease in diabetes mellitus, we studied platelet aggregation in 15 normal, 7 prediabetic, 12 latent, and 20 frankly diabetic subjects. Platelets from latent and frank diabetics showed increased platelet aggregation 4 minutes after adding adenosine 5'-diphosphate (60% verus 29% at 1.0 mu-M), epinephrine (46% versus 14% at 0.25 mu-M), and collagen (72% versus 17% at 0.25 mu-g/ml). Three prediabetics had increased platelet aggregation. Platelet sensitivity to aggregating agents was most marked in frank diabetics, intermediate in latent diabetics, and least in prediabetics. Second-phase platelet aggregation was reversed with acetylsalicylic acid, intravenous tolbutamide, and oral glucose administration. We conclude that platelet aggregation may be increased early in diabetes mellitus and may be involved in the genesis of diabetic microangiopathy. Prospective studies on the effect of therapeutic agents such as acetylsalicylic acid on the natural course of diabetic vascular disease are indicated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1138583     DOI: 10.7326/0003-4819-82-6-733

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  46 in total

Review 1.  Diabetes mellitus and the nervous system.

Authors:  P J Watkins; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

Review 2.  Antiplatelet agents and diabetic vascular disease.

Authors:  J A Colwell
Journal:  Trans Am Clin Climatol Assoc       Date:  1987

3.  Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.

Authors:  D M Gibb; D Dunger; M Levin; D Grant; P Jones; T M Barratt
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

4.  The diabetic foot.

Authors:  J A Hunt
Journal:  Can Fam Physician       Date:  1990-10       Impact factor: 3.275

5.  Effect of eicosapentaenoic acid ethyl ester on proteinuria of streptozotocin-induced diabetes mellitus in rats.

Authors:  M Fujikawa; K Yamazaki; S Sawazaki; H Taki; M Kaneda; M Urakaze; T Hamazaki; S Yano; T Fujita
Journal:  Lipids       Date:  1989-09       Impact factor: 1.880

6.  Platelet aggregability during the first two years of type 1 (insulin-dependent) diabetes mellitus in children.

Authors:  A M Kobbah; U Ewald; T Tuvemo
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

7.  Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.

Authors:  G Ranieri; V Filitti; A Andriani; M V Bonfantino; G Lamontanara; A Cavallo; M Milani; R De Cesaris
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

8.  Reduction of platelet aggregation induced by euglycaemic insulin clamp.

Authors:  K Hiramatsu; H Nozaki; S Arimori
Journal:  Diabetologia       Date:  1987-05       Impact factor: 10.122

9.  Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 in type 1 (insulin-dependent) diabetic patients during exercise.

Authors:  T Mourits-Andersen; I W Jensen; P N Jensen; J Ditzel; J Dyerberg
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

10.  Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.

Authors:  L R Queen; Y Ji; I Goubareva; A Ferro
Journal:  Diabetologia       Date:  2003-10-23       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.